Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in hematopoietic malignancies

Name: Work Video:
Duration: 3 min 30 s
Jean‐Pierre J. Issa; Guillermo Garcia‐Manero; Francis J. Giles; Rajan K. Mannari; Deborah A. Thomas; Stefan Faderl; Emel Bayar; John F. Lyons; C Rosenfeld; Jorge E. Cortés; Hagop M. Kantarjian
{'id': 'https://openalex.org/W2109895173', 'doi': 'https://doi.org/10.1182/blood-2003-03-0687', 'title': 'Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in hematopoietic malignancies', 'display_name': 'Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in hematopoietic malignancies', 'publication_year': 2003, 'publication_date': '2003-11-10', 'ids': {'openalex': 'https://openalex.org/W2109895173', 'doi': 'https://doi.org/10.1182/blood-2003-03-0687', 'mag': '2109895173', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/14604977'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1182/blood-2003-03-0687', 'pdf_url': 'https://ashpublications.org/blood/article-pdf/103/5/1635/1696309/zh800504001635.pdf', 'source': {'id': 'https://openalex.org/S200071133', 'display_name': 'Blood', 'issn_l': '0006-4971', 'issn': ['0006-4971', '1528-0020'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://ashpublications.org/blood/article-pdf/103/5/1635/1696309/zh800504001635.pdf', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5062330946', 'display_name': 'Jean‐Pierre J. Issa', 'orcid': 'https://orcid.org/0000-0003-2258-5030'}, 'institutions': [{'id': 'https://openalex.org/I4210149223', 'display_name': 'SuperGen (United States)', 'ror': 'https://ror.org/049922318', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210149223']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jean-Pierre J. Issa', 'raw_affiliation_strings': ['From the Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX; and SuperGen Inc, Dublin, CA.', 'SuperGen Inc, Dublin, CA.'], 'affiliations': [{'raw_affiliation_string': 'SuperGen Inc, Dublin, CA.', 'institution_ids': ['https://openalex.org/I4210149223']}, {'raw_affiliation_string': 'From the Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX; and SuperGen Inc, Dublin, CA.', 'institution_ids': ['https://openalex.org/I4210149223']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5061026876', 'display_name': 'Guillermo Garcia‐Manero', 'orcid': 'https://orcid.org/0000-0002-3631-2482'}, 'institutions': [{'id': 'https://openalex.org/I4210149223', 'display_name': 'SuperGen (United States)', 'ror': 'https://ror.org/049922318', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210149223']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Guillermo Garcia-Manero', 'raw_affiliation_strings': ['From the Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX; and SuperGen Inc, Dublin, CA.', 'SuperGen Inc, Dublin, CA.'], 'affiliations': [{'raw_affiliation_string': 'SuperGen Inc, Dublin, CA.', 'institution_ids': ['https://openalex.org/I4210149223']}, {'raw_affiliation_string': 'From the Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX; and SuperGen Inc, Dublin, CA.', 'institution_ids': ['https://openalex.org/I4210149223']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5061285204', 'display_name': 'Francis J. Giles', 'orcid': 'https://orcid.org/0000-0002-6919-0231'}, 'institutions': [{'id': 'https://openalex.org/I4210149223', 'display_name': 'SuperGen (United States)', 'ror': 'https://ror.org/049922318', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210149223']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Francis J. Giles', 'raw_affiliation_strings': ['From the Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX; and SuperGen Inc, Dublin, CA.', 'SuperGen Inc, Dublin, CA.'], 'affiliations': [{'raw_affiliation_string': 'SuperGen Inc, Dublin, CA.', 'institution_ids': ['https://openalex.org/I4210149223']}, {'raw_affiliation_string': 'From the Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX; and SuperGen Inc, Dublin, CA.', 'institution_ids': ['https://openalex.org/I4210149223']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5002329386', 'display_name': 'Rajan K. Mannari', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210149223', 'display_name': 'SuperGen (United States)', 'ror': 'https://ror.org/049922318', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210149223']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Rajan Mannari', 'raw_affiliation_strings': ['From the Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX; and SuperGen Inc, Dublin, CA.', 'SuperGen Inc, Dublin, CA.'], 'affiliations': [{'raw_affiliation_string': 'SuperGen Inc, Dublin, CA.', 'institution_ids': ['https://openalex.org/I4210149223']}, {'raw_affiliation_string': 'From the Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX; and SuperGen Inc, Dublin, CA.', 'institution_ids': ['https://openalex.org/I4210149223']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5038307470', 'display_name': 'Deborah A. Thomas', 'orcid': 'https://orcid.org/0000-0002-2656-343X'}, 'institutions': [{'id': 'https://openalex.org/I4210149223', 'display_name': 'SuperGen (United States)', 'ror': 'https://ror.org/049922318', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210149223']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Deborah Thomas', 'raw_affiliation_strings': ['From the Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX; and SuperGen Inc, Dublin, CA.', 'SuperGen Inc, Dublin, CA.'], 'affiliations': [{'raw_affiliation_string': 'SuperGen Inc, Dublin, CA.', 'institution_ids': ['https://openalex.org/I4210149223']}, {'raw_affiliation_string': 'From the Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX; and SuperGen Inc, Dublin, CA.', 'institution_ids': ['https://openalex.org/I4210149223']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5046097970', 'display_name': 'Stefan Faderl', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210149223', 'display_name': 'SuperGen (United States)', 'ror': 'https://ror.org/049922318', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210149223']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Stefan Faderl', 'raw_affiliation_strings': ['From the Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX; and SuperGen Inc, Dublin, CA.', 'SuperGen Inc, Dublin, CA.'], 'affiliations': [{'raw_affiliation_string': 'SuperGen Inc, Dublin, CA.', 'institution_ids': ['https://openalex.org/I4210149223']}, {'raw_affiliation_string': 'From the Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX; and SuperGen Inc, Dublin, CA.', 'institution_ids': ['https://openalex.org/I4210149223']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5109111774', 'display_name': 'Emel Bayar', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210149223', 'display_name': 'SuperGen (United States)', 'ror': 'https://ror.org/049922318', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210149223']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Emel Bayar', 'raw_affiliation_strings': ['From the Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX; and SuperGen Inc, Dublin, CA.', 'SuperGen Inc, Dublin, CA.'], 'affiliations': [{'raw_affiliation_string': 'SuperGen Inc, Dublin, CA.', 'institution_ids': ['https://openalex.org/I4210149223']}, {'raw_affiliation_string': 'From the Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX; and SuperGen Inc, Dublin, CA.', 'institution_ids': ['https://openalex.org/I4210149223']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5050224107', 'display_name': 'John F. Lyons', 'orcid': 'https://orcid.org/0009-0002-7080-7937'}, 'institutions': [{'id': 'https://openalex.org/I4210149223', 'display_name': 'SuperGen (United States)', 'ror': 'https://ror.org/049922318', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210149223']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'John Lyons', 'raw_affiliation_strings': ['From the Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX; and SuperGen Inc, Dublin, CA.', 'SuperGen Inc, Dublin, CA.'], 'affiliations': [{'raw_affiliation_string': 'SuperGen Inc, Dublin, CA.', 'institution_ids': ['https://openalex.org/I4210149223']}, {'raw_affiliation_string': 'From the Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX; and SuperGen Inc, Dublin, CA.', 'institution_ids': ['https://openalex.org/I4210149223']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5112823148', 'display_name': 'C Rosenfeld', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210149223', 'display_name': 'SuperGen (United States)', 'ror': 'https://ror.org/049922318', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210149223']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Craig S. Rosenfeld', 'raw_affiliation_strings': ['From the Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX; and SuperGen Inc, Dublin, CA.', 'SuperGen Inc, Dublin, CA.'], 'affiliations': [{'raw_affiliation_string': 'From the Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX; and SuperGen Inc, Dublin, CA.', 'institution_ids': ['https://openalex.org/I4210149223']}, {'raw_affiliation_string': 'SuperGen Inc, Dublin, CA.', 'institution_ids': ['https://openalex.org/I4210149223']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5015101485', 'display_name': 'Jorge E. Cortés', 'orcid': 'https://orcid.org/0000-0002-8636-1071'}, 'institutions': [{'id': 'https://openalex.org/I4210149223', 'display_name': 'SuperGen (United States)', 'ror': 'https://ror.org/049922318', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210149223']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jorge Cortes', 'raw_affiliation_strings': ['From the Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX; and SuperGen Inc, Dublin, CA.', 'SuperGen Inc, Dublin, CA.'], 'affiliations': [{'raw_affiliation_string': 'SuperGen Inc, Dublin, CA.', 'institution_ids': ['https://openalex.org/I4210149223']}, {'raw_affiliation_string': 'From the Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX; and SuperGen Inc, Dublin, CA.', 'institution_ids': ['https://openalex.org/I4210149223']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5090435894', 'display_name': 'Hagop M. Kantarjian', 'orcid': 'https://orcid.org/0000-0002-1908-3307'}, 'institutions': [{'id': 'https://openalex.org/I4210149223', 'display_name': 'SuperGen (United States)', 'ror': 'https://ror.org/049922318', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210149223']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Hagop M. Kantarjian', 'raw_affiliation_strings': ['From the Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX; and SuperGen Inc, Dublin, CA.', 'SuperGen Inc, Dublin, CA.'], 'affiliations': [{'raw_affiliation_string': 'SuperGen Inc, Dublin, CA.', 'institution_ids': ['https://openalex.org/I4210149223']}, {'raw_affiliation_string': 'From the Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX; and SuperGen Inc, Dublin, CA.', 'institution_ids': ['https://openalex.org/I4210149223']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 5000, 'currency': 'USD', 'value_usd': 5000, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 19.624, 'has_fulltext': True, 'fulltext_origin': 'pdf', 'cited_by_count': 796, 'citation_normalized_percentile': {'value': 0.999978, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 99, 'max': 100}, 'biblio': {'volume': '103', 'issue': '5', 'first_page': '1635', 'last_page': '1640'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10269', 'display_name': 'Epigenetics and DNA Methylation', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10269', 'display_name': 'Epigenetics and DNA Methylation', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10309', 'display_name': 'Acute Myeloid Leukemia Research', 'score': 0.9984, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10950', 'display_name': 'Acute Lymphoblastic Leukemia research', 'score': 0.9947, 'subfield': {'id': 'https://openalex.org/subfields/2739', 'display_name': 'Public Health, Environmental and Occupational Health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/decitabine', 'display_name': 'Decitabine', 'score': 0.990708}, {'id': 'https://openalex.org/keywords/hypomethylating-agent', 'display_name': 'Hypomethylating agent', 'score': 0.76043475}, {'id': 'https://openalex.org/keywords/azacitidine', 'display_name': 'Azacitidine', 'score': 0.57143474}, {'id': 'https://openalex.org/keywords/maximum-tolerated-dose', 'display_name': 'Maximum tolerated dose', 'score': 0.45494437}], 'concepts': [{'id': 'https://openalex.org/C2780235182', 'wikidata': 'https://www.wikidata.org/wiki/Q1181878', 'display_name': 'Decitabine', 'level': 5, 'score': 0.990708}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.7644423}, {'id': 'https://openalex.org/C2776012956', 'wikidata': 'https://www.wikidata.org/wiki/Q17125294', 'display_name': 'Hypomethylating agent', 'level': 5, 'score': 0.76043475}, {'id': 'https://openalex.org/C2777844706', 'wikidata': 'https://www.wikidata.org/wiki/Q422504', 'display_name': 'Deoxycytidine', 'level': 4, 'score': 0.58465886}, {'id': 'https://openalex.org/C2776239401', 'wikidata': 'https://www.wikidata.org/wiki/Q416451', 'display_name': 'Azacitidine', 'level': 5, 'score': 0.57143474}, {'id': 'https://openalex.org/C2778461978', 'wikidata': 'https://www.wikidata.org/wiki/Q29496', 'display_name': 'Leukemia', 'level': 2, 'score': 0.56360453}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.4957386}, {'id': 'https://openalex.org/C2777334693', 'wikidata': 'https://www.wikidata.org/wiki/Q659446', 'display_name': 'Maximum tolerated dose', 'level': 3, 'score': 0.45494437}, {'id': 'https://openalex.org/C2778729363', 'wikidata': 'https://www.wikidata.org/wiki/Q11688946', 'display_name': 'Myeloid leukemia', 'level': 2, 'score': 0.42860216}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.4189126}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.37351805}, {'id': 'https://openalex.org/C29730261', 'wikidata': 'https://www.wikidata.org/wiki/Q274160', 'display_name': 'Toxicity', 'level': 2, 'score': 0.2837333}, {'id': 'https://openalex.org/C2776694085', 'wikidata': 'https://www.wikidata.org/wiki/Q974135', 'display_name': 'Chemotherapy', 'level': 2, 'score': 0.2681859}, {'id': 'https://openalex.org/C190727270', 'wikidata': 'https://www.wikidata.org/wiki/Q874745', 'display_name': 'DNA methylation', 'level': 4, 'score': 0.23050693}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.0871976}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C150194340', 'wikidata': 'https://www.wikidata.org/wiki/Q26972', 'display_name': 'Gene expression', 'level': 3, 'score': 0.0}, {'id': 'https://openalex.org/C2780258809', 'wikidata': 'https://www.wikidata.org/wiki/Q414143', 'display_name': 'Gemcitabine', 'level': 3, 'score': 0.0}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D000964', 'descriptor_name': 'Antimetabolites, Antineoplastic', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D001374', 'descriptor_name': 'Azacitidine', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': True}, {'descriptor_ui': 'D001374', 'descriptor_name': 'Azacitidine', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D019337', 'descriptor_name': 'Hematologic Neoplasms', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D007938', 'descriptor_name': 'Leukemia', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D009196', 'descriptor_name': 'Myeloproliferative Disorders', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D000293', 'descriptor_name': 'Adolescent', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000368', 'descriptor_name': 'Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000369', 'descriptor_name': 'Aged, 80 and over', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000964', 'descriptor_name': 'Antimetabolites, Antineoplastic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001374', 'descriptor_name': 'Azacitidine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018797', 'descriptor_name': 'Cell Cycle Proteins', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D018797', 'descriptor_name': 'Cell Cycle Proteins', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002454', 'descriptor_name': 'Cell Differentiation', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002648', 'descriptor_name': 'Child', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002675', 'descriptor_name': 'Child, Preschool', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015331', 'descriptor_name': 'Cohort Studies', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D050762', 'descriptor_name': 'Cyclin-Dependent Kinase Inhibitor p15', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019175', 'descriptor_name': 'DNA Methylation', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015254', 'descriptor_name': 'DNA Modification Methylases', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D015254', 'descriptor_name': 'DNA Modification Methylases', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000077209', 'descriptor_name': 'Decitabine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004305', 'descriptor_name': 'Dose-Response Relationship, Drug', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D020868', 'descriptor_name': 'Gene Silencing', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019337', 'descriptor_name': 'Hematologic Neoplasms', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007621', 'descriptor_name': 'Karyotyping', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007938', 'descriptor_name': 'Leukemia', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008745', 'descriptor_name': 'Methylation', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009196', 'descriptor_name': 'Myeloproliferative Disorders', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013997', 'descriptor_name': 'Time Factors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016896', 'descriptor_name': 'Treatment Outcome', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D025521', 'descriptor_name': 'Tumor Suppressor Proteins', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D025521', 'descriptor_name': 'Tumor Suppressor Proteins', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1182/blood-2003-03-0687', 'pdf_url': 'https://ashpublications.org/blood/article-pdf/103/5/1635/1696309/zh800504001635.pdf', 'source': {'id': 'https://openalex.org/S200071133', 'display_name': 'Blood', 'issn_l': '0006-4971', 'issn': ['0006-4971', '1528-0020'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/14604977', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1182/blood-2003-03-0687', 'pdf_url': 'https://ashpublications.org/blood/article-pdf/103/5/1635/1696309/zh800504001635.pdf', 'source': {'id': 'https://openalex.org/S200071133', 'display_name': 'Blood', 'issn_l': '0006-4971', 'issn': ['0006-4971', '1528-0020'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being', 'score': 0.81}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 33, 'referenced_works': ['https://openalex.org/W1552528612', 'https://openalex.org/W1556996865', 'https://openalex.org/W1584238095', 'https://openalex.org/W1588226643', 'https://openalex.org/W163413690', 'https://openalex.org/W1879966002', 'https://openalex.org/W1968263601', 'https://openalex.org/W1970161464', 'https://openalex.org/W1972933434', 'https://openalex.org/W1974840866', 'https://openalex.org/W1994465394', 'https://openalex.org/W2022733644', 'https://openalex.org/W2033841166', 'https://openalex.org/W2054984477', 'https://openalex.org/W2069010738', 'https://openalex.org/W2078028724', 'https://openalex.org/W2086492419', 'https://openalex.org/W2098976753', 'https://openalex.org/W2106680700', 'https://openalex.org/W2117809535', 'https://openalex.org/W2128146359', 'https://openalex.org/W2145337538', 'https://openalex.org/W2145750252', 'https://openalex.org/W2153901235', 'https://openalex.org/W2168387971', 'https://openalex.org/W2168657585', 'https://openalex.org/W2169452890', 'https://openalex.org/W2286344822', 'https://openalex.org/W2412316950', 'https://openalex.org/W2412410165', 'https://openalex.org/W2614322702', 'https://openalex.org/W305459207', 'https://openalex.org/W4234183534'], 'related_works': ['https://openalex.org/W4245640489', 'https://openalex.org/W3203236595', 'https://openalex.org/W2559444916', 'https://openalex.org/W2436188093', 'https://openalex.org/W2409251897', 'https://openalex.org/W2054507167', 'https://openalex.org/W2051650123', 'https://openalex.org/W1998703095', 'https://openalex.org/W1983754555', 'https://openalex.org/W1930210344'], 'abstract_inverted_index': None, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2109895173', 'counts_by_year': [{'year': 2024, 'cited_by_count': 12}, {'year': 2023, 'cited_by_count': 25}, {'year': 2022, 'cited_by_count': 19}, {'year': 2021, 'cited_by_count': 27}, {'year': 2020, 'cited_by_count': 22}, {'year': 2019, 'cited_by_count': 33}, {'year': 2018, 'cited_by_count': 29}, {'year': 2017, 'cited_by_count': 32}, {'year': 2016, 'cited_by_count': 28}, {'year': 2015, 'cited_by_count': 36}, {'year': 2014, 'cited_by_count': 41}, {'year': 2013, 'cited_by_count': 46}, {'year': 2012, 'cited_by_count': 46}], 'updated_date': '2024-12-09T14:43:37.103961', 'created_date': '2016-06-24'}
Publication Information

Basic Information

Access and Citation

AI Researcher Chatbot

Primary Location

Authors

Topics

Keywords

Related Works
